Summary:
Stem cell research continues to push the boundaries of science offering glimpses on how an organism develops from a single cell and how it repairs and replaces damaged cells at maturity. Although Aegera's main focus is currently on cancer therapeutics, we have a continued interest in exploring the unlimited potential of cell based therapies through partnerships and collaborations, supported through externally generated funds.
Visit Aegera Therapeutics Inc..

Description (Web site quote):
Aegera Therapeutics is a private oncology company dedicated to a single therapeutic goal: extending and enhancing the lives of cancer patients. Cancer is a devastating disease with sub-optimal treatments, many of which induce serious, debilitating side effects. Aegera, through its expertise in controlling apoptosis, is developing new therapeutics to significantly enhance existing cancer treatment paradigms. Aegera is targeting the delivery of two new oncology drugs to the clinic by the end of 2004, developing exciting proof-of-principle for multiple line extension opportunities, and has a rich development pipeline and significant business development potential.
Visit Aegera Therapeutics Inc..